154 related articles for article (PubMed ID: 9240175)
21. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
22. Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma.
Dosquet C; Schaetz A; Faucher C; Lepage E; Wautier JL; Richard F; Cabane J
Eur J Cancer; 1994; 30A(2):162-7. PubMed ID: 8155390
[TBL] [Abstract][Full Text] [Related]
23. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
[TBL] [Abstract][Full Text] [Related]
24. Lymph node dissection in renal cell carcinoma.
Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of increased preoperative serum high sensitive C-reactive protein and procalcitonin levels on grade and stage of clear cell renal cell carcinoma.
Hamidi N; Gökçe MI; Süer E; Baltaci S
Clin Nephrol; 2015 Apr; 83(4):225-30. PubMed ID: 25707457
[TBL] [Abstract][Full Text] [Related]
26. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
[TBL] [Abstract][Full Text] [Related]
27. Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy.
Fujikawa K; Matsui Y; Miura K; Kobayashi T; Oka H; Fukuzawa S; Takeuchi H
J Urol; 2000 Sep; 164(3 Pt 1):673-5. PubMed ID: 10953123
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic factors in patients with stage 4B renal cell carcinoma following nephrectomy].
Onishi T; Ohishi Y; Masuda F; Iizuka N; Suzuki Y; Shirakawa H; Hatano T; Tomita M
Nihon Hinyokika Gakkai Zasshi; 1994 Nov; 85(11):1664-72. PubMed ID: 7807775
[TBL] [Abstract][Full Text] [Related]
29. Tumour-associated trypsin inhibitor and renal cell carcinoma.
Meria P; Toubert ME; Cussenot O; Bassi S; Janssen T; Desgrandchamps F; Cortesse A; Schlageter MH; Teillac P; Le Duc A
Eur Urol; 1995; 27(3):223-6. PubMed ID: 7601186
[TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical and pathological characteristics in incidentally detected and suspected renal carcinoma.
Ueda T; Yasumasu T; Uozumi J; Naito S
Br J Urol; 1991 Nov; 68(5):470-2. PubMed ID: 1747720
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of lymph node dissection in renal cell carcinoma.
Matsuyama H; Hirata H; Korenaga Y; Wada T; Nagao K; Yamaguchi S; Yoshihiro S; Naito K
Scand J Urol Nephrol; 2005; 39(1):30-5. PubMed ID: 15764268
[TBL] [Abstract][Full Text] [Related]
32. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
[TBL] [Abstract][Full Text] [Related]
33. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis.
Tsuji Y; Goto A; Hara I; Ataka K; Yamashita C; Okita Y; Kamidono S
J Vasc Surg; 2001 Apr; 33(4):789-96. PubMed ID: 11296333
[TBL] [Abstract][Full Text] [Related]
35. A proposed staging system for primary gastric lymphoma.
Shimodaira M; Tsukamoto Y; Niwa Y; Goto H; Hase S; Hayakawa T; Nagasaka T
Cancer; 1994 Jun; 73(11):2709-15. PubMed ID: 8194010
[TBL] [Abstract][Full Text] [Related]
36. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of the penis--appraisal of a modified tumour-staging system.
Heyns CF; van Vollenhoven P; Steenkamp JW; Allen FJ; van Velden DJ
Br J Urol; 1997 Aug; 80(2):307-12. PubMed ID: 9284207
[TBL] [Abstract][Full Text] [Related]
38. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Miyazawa Y; Shihratori T; Hayashi H; Aoki T; Sugaya M; Gunji Y; Kobayashi S; Ochiai T
Dis Esophagus; 2003; 16(2):102-6. PubMed ID: 12823207
[TBL] [Abstract][Full Text] [Related]
40. Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung.
Tsutani Y; Murakami S; Miyata Y; Nakayama H; Yoshimura M; Okada M
Eur J Cardiothorac Surg; 2015 Jun; 47(6):1022-6. PubMed ID: 25293403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
